rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: nivagen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler nivagen pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 6 mg/1

Manufacturer
Nivagen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 75834-136
Product ID 75834-136_e272f7d1-d782-4ff1-919c-784c91ee024d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203844
Listing Expiration 2026-12-31
Marketing Start 2017-09-04

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 75834136
Hyphenated Format 75834-136

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UPC
0375834133607 0375834134604 0375834135601 0375834136608
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA203844 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE, PLASTIC (75834-136-05)
  • 60 CAPSULE in 1 BOTTLE, PLASTIC (75834-136-60)
source: ndc

Packages (2)

75834-136-05 500 CAPSULE in 1 BOTTLE, PLASTIC (75834-136-05) 75834-136-60 60 CAPSULE in 1 BOTTLE, PLASTIC (75834-136-60)

Ingredients (1)

rivastigmine tartrate (6 mg/1)

Linked Drug Pages (1)

RIVASTIGMINE TARTRATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e272f7d1-d782-4ff1-919c-784c91ee024d", "openfda": {"upc": ["0375834133607", "0375834134604", "0375834135601", "0375834136608"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (75834-136-05)", "package_ndc": "75834-136-05", "marketing_start_date": "20170904"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (75834-136-60)", "package_ndc": "75834-136-60", "marketing_start_date": "20170904"}], "brand_name": "RIVASTIGMINE TARTRATE", "product_id": "75834-136_e272f7d1-d782-4ff1-919c-784c91ee024d", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "75834-136", "generic_name": "RIVASTIGMINE TARTRATE", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIVASTIGMINE TARTRATE", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "6 mg/1"}], "application_number": "ANDA203844", "marketing_category": "ANDA", "marketing_start_date": "20170904", "listing_expiration_date": "20261231"}